← Open Payments lookup

JUSTIN PETRIE: Open Payments

NPI 1164816443 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,080 in 114 payments from 17 companies in 2025. Trend: 2023 $664 · 2024 $1,343 · 2025 $2,080

Food & beverage: $2,080
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.12$284
Neurocrine BioSciences, Inc.13$282
ABBVIE INC.17$275
Otsuka America Pharmaceutical, Inc.14$213
Alkermes, Inc.9$202
Teva Pharmaceuticals USA, Inc.8$178
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$169
Takeda Pharmaceuticals U.S.A., Inc.4$109
Vanda Pharmaceuticals Inc.2$73
Almatica Pharma LLC4$66

Products named: COBENFY, INGREZZA, VRAYLAR, ARISTADA, REXULTI, CAPLYTA, AUSTEDO XR, TRINTELLIX.

Industry payments across NV — which companies pay providers there.